Navigation Links
UC San Diego researchers reverse pulmonary arterial hypertension in mouse models
Date:10/25/2009

Researchers at the University of California, San Diego, have identified a key protein that promotes the development of pulmonary arterial hypertension in humans and mice. This groundbreaking discovery has implications for future drug therapies that may extend the life of patients with pulmonary arterial hypertension and prevent the need for lung transplantation, currently the only cure for this debilitating disease.

In a paper to be published online in Nature Medicine on October 25, Patricia Thistlethwaite, MD, PhD, Professor of Surgery and cardiothoracic surgeon in UCSD's Department of Surgery, and colleagues describe the genetic pathway by which vascular smooth muscle cells associated with pulmonary arterial hypertension are switched on to proliferate by a receptor protein called Notch-3. With this finding, the researchers were able to block and reverse the pathway of disease in mice.

"The UCSD team found that pulmonary hypertension is characterized by overexpression of Notch-3 and that the severity of the disease correlates with the amount of this protein in the lung," said Thistelthwaite. "We showed that a mouse model lacking this protein does not develop pulmonary hypertension, and in addition, that the disease can be effectively treated with an enzyme called γ-secretase inhibitor, which blocks Notch-3 activation."

In Thistlethwaite's laboratory, mice with pulmonary arterial hypertension that were treated with the γ-secretase inhibitor showed reversal of the disease. Forms of this drug are currently in use in Phase 1 trials for the treatment of Alzheimer's disease.

Pulmonary arterial hypertension is a form of high blood pressure in the lung's arteries. The disease begins when tiny arteries in the lungs become narrow, blocked or destroyed causing resistance to blood to flow. As the pressure builds, the heart's lower right chamber becomes overworked and weakens, leading to ventricular failure. The condi
'/>"/>

Contact: Jackie Carr
jcarr@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Johnson Matthey Expands San Diego Facility
2. San Diego Hospice and The Institute for Palliative Medicine Program Wins National American Psychiatric Association Gold Achievement Award
3. Komen San Diego Ramps Up for Important Race for the Cure(R) November 1
4. ONRAD Announces New Partnership with La Maestra Community Health Centers of San Diego, CA
5. CTIA, West Wireless Health Institute, Qualcomm, and CommNexus San Diego Present: San Diego - The Nations Hub for Wireless Healthcare
6. MedicAlert Foundation to Offer 24-Hour Emergency Medical Information Services for Deaf Community Services of San Diego, Inc.
7. 4,000 numbers crunchers count on San Diego
8. Susan G. Komen for the Cure(R), San Diego Releases Community Profile Unveiling Alarming Statistics About Breast Cancer in San Diego County
9. Young Survivor and Advocate, Amanda Nixon, Named 2009 Honorary Breast Cancer Survivor by Susan G. Komen for the Cure, San Diego
10. San Diego Firm Offers Free Seminar on Becoming a Professional Health Coach
11. Labor Day Beach Visitors Will See Giant Hydroponics Marijuana Bud Banner Flying Over Los Angeles & San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UC San Diego researchers reverse pulmonary arterial hypertension in mouse models
(Date:9/18/2014)... 2014 Pathways Home Health & ... position of Chief Medical Director. Prior to accepting ... Pathways programs including Pathways KIDS, adult palliative care, and ... and Santa Clara Counties. , In her new ... Pathway’s patient care program. She will supervise five medical ...
(Date:9/18/2014)... Sept. 18, 2014 (HealthDay News) -- Imaging technology has ... stress disorder (PTSD) manifest in the brain, according to ... health condition that can cause a wide range of ... being in a constant state of stress and avoiding ... the study. Researchers identified a specific opioid receptor ...
(Date:9/18/2014)... 2014 -- Only about half of all pregnant women ... thousands of moms-to-be and their babies at increased risk of ... be a routine part of prenatal care," said Edward McCabe, ... should offer their pregnant patients a flu shot each year ... , A report by the U.S. Centers for Disease Control ...
(Date:9/18/2014)... in disadvantaged neighborhoods have worse musculoskeletal pain outcomes ... vehicle collision than individuals from higher socioeconomic status ... as age, sex, income, education, and employment status. ... research study led by Samuel McLean, MD, MPH, ... the University of North Carolina School of Medicine. ...
(Date:9/18/2014)... COPENHAGEN, Denmark and CAMBRIDGE, Massachusetts, U.S.A., September 18, ... Tech) is providing sequencing service to Denmark-based DLF-Trifolium ... (MBG) at Aarhus University in an effort to ... varieties by employing genomic selection (GS) methods. , ... selection, which in contrast to the traditional QTL-based ...
Breaking Medicine News(10 mins):Health News:Dr. Ellen Brown Promoted to Chief Medical Director at Pathways Home Health & Hospice 2Health News:Research Shows Possible Neurological Patterns for PTSD Symptoms 2Health News:Research Shows Possible Neurological Patterns for PTSD Symptoms 3Health News:Flu vaccine for expectant moms a top priority 2Health News:Living in a disadvantaged neighborhood worsens musculoskeletal pain outcomes after trauma 2Health News:BGI Tech, DLF-Trifolium A/S, and Aarhus University applying genomic selection methods 2
... representing the Women,s Dermatologic Society (WDS) will, help Texan ... skin cancer screenings and sun safety tips ... Texas, Sept. 18 Even though higher altitudes,mean heightened ... enjoying the upcoming Plano Hot Air Balloon Festival will ...
... cells and other tissue in the laboratory in conditions similar ... , The technology, developed and patented by scientists at Durham ... scaffold which allows cells to be grown in a more ... of a Petri dish. , Evidence gathered by the ...
... that training programs for females to restore balance between ... could help reduce the disproportionately high number of ACL ... shows that the amount of preparatory muscle action in ... is associated with knee positions that are considered at ...
... for Treating Major Symptoms of Lumbar ... ... KYPH ) today announced that Dr. Michael Marks, orthopaedic spine,surgeon from ... will be interviewed together on,American Health Radio, the nationally-syndicated health radio ...
... 18 AMERIGROUP,Corporation (NYSE: AGP ) today ... Centers for Medicaid and Medicare Services (CMS) to ... traditional Medicare,Advantage health plans to address the specialized ... states. AMERIGROUP currently coordinates care for approximately ...
... heard,arguments yesterday in the lawsuit brought in Superior Court ... time during the,U.S. Medical Licensing Examination (USMLE). "Fairness ... remain the,overriding concerns of the exam,s sponsors," said Joseph ... Examiners, which co-sponsors the,exam and was named in the ...
Cached Medicine News:Health News:Sun Safety Outreach to Families Takes Flight at the Plano Hot Air Balloon Festival 2Health News:Sun Safety Outreach to Families Takes Flight at the Plano Hot Air Balloon Festival 3Health News:Cell growth technology promises more successful drug development 2Health News:Cell growth technology promises more successful drug development 3Health News:Muscle patterns in women may be linked to at risk positioning for ACL tears 2Health News:Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007 2Health News:Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007 3Health News:AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States 2Health News:AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States 3Health News:Massachusetts State Court Hears Suit by Breastfeeding Mother on Medical Licensing Exam 2
(Date:9/18/2014)... , Sept. 18, 2014   Regulus Therapeutics ... biopharmaceutical company leading the discovery and development of ... initiated its ATHENA natural history of disease study ... kidney disease with no approved therapy. The ATHENA ... of renal function markers such as Glomerular Filtration ...
(Date:9/18/2014)... , Sept. 18, 2014 Just days before ... a three-day quarantine to contain the spread of Ebola, World ... medical relief supplies – thanks to private donations. ... United States , through its affiliate McKesson Medical-Surgical donated ... the entire country of Sierra Leone,s ...
(Date:9/17/2014)... Sept. 17, 2014 North America Gynecological ... GlobalData,s new report, "North America ... market data on the North America Gynecological Devices ... US dollars, volume (in units) and average prices ... Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical ...
Breaking Medicine Technology:Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 2World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 3World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 4North America Gynecological Devices Market Outlook to 2020 2North America Gynecological Devices Market Outlook to 2020 3
... Bias, DURHAM, N.C., Sept. 15 Less ... treatment are eventually published in,medical journals, according to ... Oncologist.", (LOGO: http://www.newscom.com/cgi-bin/prnh/20080627/CLF051LOGO ), ... of Washington and,Fred Hutchinson Cancer Research Center, Seattle, ...
... a novel ... macrolide-related drug class, WATERTOWN, Mass., Sept. ... molecule anti-infective drugs, announced,today the initiation of a Phase 1 ... novel,macrolide-related drug class with a distinct resistance profile. The,clinical development ...
Cached Medicine Technology:Most Cancer Treatment Studies Aren't Published, Study Finds 2Most Cancer Treatment Studies Aren't Published, Study Finds 3Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA 2Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA 3
Trilogy Pacemakers incorporates the clinically proven Omniscence™ accelerometer sensor with it's automatic alogorithms. The Trilogy family of pacemakers feature an array of products for bradyar...
The Regency family of pacemakers offers advanced, easy-to-use rate-responsive and nonrate-responsive devices....
... ADx pacemaker family, which ... dual-chamber pacemaker, provides clinicians ... including the revolutionary AF ... U.S. commercially approved algorithm ...
... ADx pacemaker family, which includes ... provides clinicians with the most ... the revolutionary AF Suppression™ algorithm, ... commercially approved algorithm designed to ...
Medicine Products: